{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:24:35Z","timestamp":1777886675129,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Diseases Now"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.idnow.2026.105259","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T09:05:17Z","timestamp":1772096717000},"page":"105259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Combination of ertapenem and penicillin M or cefazolin in the treatment of methicillin-susceptible Staphylococcus aureus bacteremia: multicenter case series"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5170-6957","authenticated-orcid":false,"given":"Louis","family":"Bohard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9092-5071","authenticated-orcid":false,"given":"Yohan","family":"N\u2019Guyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8387-8761","authenticated-orcid":false,"given":"Pierre","family":"Danneels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Martin-Blondel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4589-404X","authenticated-orcid":false,"given":"Abdeljalil","family":"Zeggay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3270-178X","authenticated-orcid":false,"given":"Cl\u00e9ment","family":"Viguier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Bouiller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.idnow.2026.105259_b0005","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cmi.2022.03.015","article-title":"Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis","volume":"28","author":"Bai","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.idnow.2026.105259_b0010","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/cid\/ciad784","article-title":"The utility of risk factors to define complicated Staphylococcus aureus bacteremia in a setting with low methicillin-resistant S. aureus prevalence","volume":"78","author":"van der Vaart","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idnow.2026.105259_b0015","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jmii.2023.07.010","article-title":"Factors for mortality in patients with persistent Staphylococcus aureus bacteremia: the importance of treatment response rather than bacteremia duration","volume":"56","author":"Kim","year":"2023","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.idnow.2026.105259_b0020","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idnow.2026.105259_b0025","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S1473-3099(20)30447-3","article-title":"Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study","volume":"20","author":"Kuehl","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idnow.2026.105259_b0030","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1093\/cid\/ciaa1000","article-title":"Adjunctive daptomycin in the treatment of methicillin-susceptible Staphylococcus aureus bacteremia: a randomized, controlled trial","volume":"72","author":"Cheng","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idnow.2026.105259_b0035","article-title":"Potent activity of ertapenem plus cefazolin within staphylococcal biofilms: a contributing factor in the treatment of methicillin-susceptible Staphylococcus aureus endocarditis. open forum","volume":"9","author":"Gilbertie","year":"2022","journal-title":"Infect Dis"},{"key":"10.1016\/j.idnow.2026.105259_b0040","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1093\/jac\/dkae198","article-title":"Carbapenem combination therapy versus standard of care for persistent methicillin-susceptible Staphylococcus aureus bacteraemia","volume":"79","author":"Shah","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idnow.2026.105259_b0045","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/cid\/ciz995","article-title":"Cefazolin and ertapenem salvage therapy rapidly clears persistent methicillin-susceptible Staphylococcus aureus bacteremia","volume":"71","author":"Ulloa","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idnow.2026.105259_b0050","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlab148","article-title":"Oxacillin plus ertapenem combination therapy leads to rapid blood culture clearance and positive outcomes among patients with persistent MSSA bacteraemia: a case series","volume":"3","author":"El-Dalati","year":"2021","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.idnow.2026.105259_b0055","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1128\/AAC.01192-16","article-title":"Cefazolin and ertapenem, a synergistic combination used to clear persistent Staphylococcus aureus bacteremia","volume":"60","author":"Sakoulas","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idnow.2026.105259_b0060","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/jama.2020.0103","article-title":"Effect of vancomycin or daptomycin with vs without an antistaphylococcal \u03b2-lactam on mortality, bacteremia, relapse, or treatment failure in patients with MRSA bacteremia: a randomized clinical trial","volume":"323","author":"Tong","year":"2020","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.idnow.2026.105259_b0065","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index","volume":"47","author":"Charlson","year":"1994","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.idnow.2026.105259_b0070","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/cid\/ciz535","article-title":"Resilience of the pitt bacteremia score: 3 decades and counting","volume":"70","author":"Al-Hasan","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idnow.2026.105259_b0075","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1001\/archinte.163.17.2066","article-title":"Clinical identifiers of complicated Staphylococcus aureus bacteremia","volume":"163","author":"Fowler","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.idnow.2026.105259_b0080","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1111\/bcp.15782","article-title":"Ertapenem blood concentration: a retrospective cohort study to analyse risk of neurotoxicity","volume":"89","author":"Campany-Herrero","year":"2023","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.idnow.2026.105259_b0085","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/jac\/dkaf134","article-title":"Impact of hypoalbuminemia on patients receiving ertapenem combination therapy for methicillin-susceptible Staphylococcus aureus bacteraemia","volume":"80","author":"Shah","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idnow.2026.105259_b0090","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cmi.2014.08.003","article-title":"Association between hypoalbuminemia and mortality among subjects treated with ertapenem versus other carbapenems: prospective cohort study","volume":"21","author":"Zusman","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.idnow.2026.105259_b0095","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1177\/10600280251313874","article-title":"Impact of hypoalbuminemia on clinical outcomes in patients receiving cefazolin for methicillin-susceptible Staphylococcus aureus bacteremia","volume":"59","author":"Whitenack","year":"2025","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.idnow.2026.105259_b0100","first-page":"547","article-title":"Clearance of persistent staphylococcus aureus bacteremia in a preterm neonate with the use of combination cefazolin and ertapenem","volume":"25","author":"Akers","year":"2020","journal-title":"J Pediatr Pharmacol Ther"}],"container-title":["Infectious Diseases Now"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991926000163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991926000163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:46:52Z","timestamp":1777607212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666991926000163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2666991926000163"],"URL":"https:\/\/doi.org\/10.1016\/j.idnow.2026.105259","relation":{},"ISSN":["2666-9919"],"issn-type":[{"value":"2666-9919","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of ertapenem and penicillin M or cefazolin in the treatment of methicillin-susceptible Staphylococcus aureus bacteremia: multicenter case series","name":"articletitle","label":"Article Title"},{"value":"Infectious Diseases Now","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idnow.2026.105259","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"105259"}}